The application of vaping copyright in Australia represents a challenging and evolving legal and medical landscape. Currently, Dimethyltryptamine is a prohibited substance across the country, meaning its possession and distribution are heavily penalized under national law. While vaping copyright presents specific risks beyond those associated with